Health-related quality of life among thyroid cancer survivors: A systematic review

Clinical Endocrinology

Volumn 75, Issue 4, 2011, Pages 544-554

  Husson, Olga ^a,b   Haak, Harm R ^c   Oranje, Wilma A ^d   Mols, Floortje ^a,b   Reemst, Peter H M ^c   Van De Poll Franse, Lonneke V ^a,b  

^a TILBURG UNIVERSITY   (Netherlands)

^b Erasmus University Rotterdam and Eindhoven Cancer Registry   (Netherlands)

^c MÁXIMA MEDICAL CENTER   (Netherlands)

^d TweeSteden Hospital   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROTROPIN;

ABLATION THERAPY; ANXIETY; CANCER SURVIVAL; CANCER SURVIVOR; COGNITION; DEPRESSION; DIFFERENTIATED THYROID CANCER; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EATING HABIT; EMOTIONALITY; EUTHYROIDISM; FATIGUE; FOLLOW UP; HEMITHYROIDECTOMY; HORMONAL THERAPY; HOSTILITY; HUMAN; HYPOTHYROIDISM; MASTICATION; MEDLINE; MENTAL HEALTH; MULTICENTER STUDY (TOPIC); NECK DISSECTION; PAIN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY CONTROL; QUALITY OF LIFE; RADIOIODINE REMNANT ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ROLE STRESS; SALIVA; SCREENING TEST; SHOULDER DISEASE; SLEEP; SOCIAL INTERACTION; SOMATIZATION; SPEECH; SYSTEMATIC REVIEW; TASTE; THYROID CANCER; THYROID HORMONE THERAPY; THYROIDECTOMY; TRACHEA RESECTION; WELLBEING;

FEMALE; HUMANS; MALE; QUALITY OF LIFE; THYROID NEOPLASMS;

EID: 80052517964     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04114.x     Document Type: Review

References (46)

1. Davies, L., &, Welch, H.G., (2006) Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA, 295, 2164-2167.
2. Altekruse, S.F., Kosary, C.L., Krapcho, M., et al. SEER Cancer Statistics Review, 1975-2007. National Cancer Institute, Bethesda, MD. Available at: (accessed 7 February 2011).
3. Mendoza, A., Shaffer, B., Karakla, D., et al. (2004) Quality of life with well-differentiated thyroid cancer: treatment toxicities and their reduction. Thyroid, 14, 133-140. (Pubitemid 38375500)
4. Meier, C.A., Braverman, L.E., Ebner, S.A., et al. (1994) Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study). Journal of Clinical Endocrinology and Metabolism, 78, 188-196. (Pubitemid 24026771)
5. Tagay, S., Herpertz, S., Langkafel, M., et al. (2006) Health-related Quality of Life, depression and anxiety in thyroid cancer patients. Quality of Life Research, 15, 695-703. (Pubitemid 43843977)
6. Holzner, B., Kemmler, G., Kopp, M., et al. (2001) Quality of life in breast cancer patients-not enough attention for long-term survivors? Psychosomatics, 42, 117-123. (Pubitemid 32179999)
7. National Coalition for Cancer Survivorship. Available at: (accessed 7 February 2011).
8. Mols, F., Vingerhoets, A.J., Coebergh, J.W., et al. (2005) Quality of life among long-term breast cancer survivors: a systematic review. European Journal of Cancer, 41, 2613-2619. (Pubitemid 41613712)
9. Ware Jr, J.E., &, Sherbourne, C.D., (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473-483.
10. Shah, M.D., Witterick, I.J., Eski, S.J., et al. (2006) Quality of life in patients undergoing thyroid surgery. Journal of Otolaryngology, 35, 209-215. (Pubitemid 44368887)
11. Sywak, M., Pasieka, J.L., McFadden, S., et al. (2003) Functional results and quality of life after tracheal resection for locally invasive thyroid cancer. American Journal of Surgery, 185, 462-467. (Pubitemid 36513958)
12. Almeida, J.P., Vartanian, J.G., &, Kowalski, L.P., (2009) Clinical predictors of quality of life in patients with initial differentiated thyroid cancers. Archives of Otolaryngology-Head and Neck Surgery, 135, 342-346.
13. Dagan, T., Bedrin, L., Horowitz, Z., et al. (2004) Quality of life of well-differentiated thyroid carcinoma patients. Journal of Laryngology and Otology, 118, 537-542. (Pubitemid 39061788)
14. Pacini, F., Ladenson, P.W., Schlumberger, M., et al. (2006) Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. Journal of Clinical Endocrinology and Metabolism, 91, 926-932. (Pubitemid 43357760)
15. Taieb, D., Sebag, F., Cherenko, M., et al. (2009) Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study. Clinical Endocrinology (Oxford), 71, 115-123.
16. Schroeder, P.R., Haugen, B.R., Pacini, F., et al. (2006) A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal. Journal of Clinical Endocrinology and Metabolism, 91, 878-884. (Pubitemid 43357753)
17. Eustatia- Rutten, C.F., Corssmit, E.P., Pereira, A.M., et al. (2006) Quality of life in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial. Clinical Endocrinology (Oxford), 64, 284-291.
18. Botella- Carretero, J.I., Galan, J.M., Caballero, C., et al. (2003) Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma. Endocrine-Related Cancer, 10, 601-610. (Pubitemid 38094894)
19. Tagay, S., Herpertz, S., Langkafel, M., et al. (2005) Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatment. European Journal of Endocrinology, 153, 755-763. (Pubitemid 43020225)
20. Dow, K.H., Ferrell, B.R., &, Anello, C., (1997) Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid, 7, 613-619. (Pubitemid 27371801)
21. Davids, T., Witterick, I.J., Eski, S., et al. (2006) Three-week thyroxine withdrawal: a thyroid-specific quality of life study. Laryngoscope, 116, 250-253. (Pubitemid 44383933)
22. Chow, S.M., Au, K.H., Choy, T.S., et al. (2006) Health-related quality-of-life study in patients with carcinoma of the thyroid after thyroxine withdrawal for whole body scanning. Laryngoscope, 116, 2060-2066.
23. Golger, A., Fridman, T.R., Eski, S., et al. (2003) Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma. Journal of Endocrinological Investigation, 26, 1023-1031. (Pubitemid 38049156)
24. Dow, K.H., Ferrell, B.R., &, Anello, C., (1997) Balancing demands of cancer surveillance among survivors of thyroid cancer. Cancer Practice, 5, 289-295. (Pubitemid 28122571)
25. Ladenson, P.W., (2002) Recombinant thyrotropin for detection of recurrent thyroid cancer. Transactions of the American Clinical and Climatological Association, 113, 21-30.
26. Haugen, B.R., Pacini, F., Reiners, C., et al. (1999) A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. Journal of Clinical Endocrinology and Metabolism, 84, 3877-3885. (Pubitemid 30644169)
27. Malterling, R.R., Andersson, R.E., Falkmer, S., et al. (2010) Differentiated thyroid cancer in a Swedish county-long-term results and quality of life. Acta Oncologica, 49, 454-459.
28. Giusti, M., Sibilla, F., Cappi, C., et al. (2005) A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma. Journal of Endocrinological Investigation, 28, 599-608. (Pubitemid 43162868)
29. Tan, L.G., Nan, L., Thumboo, J., et al. (2007) Health-related quality of life in thyroid cancer survivors. Laryngoscope, 117, 507-510. (Pubitemid 46407763)
30. Crevenna, R., Zettinig, G., Keilani, M., et al. (2003) Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy. Supportive Care in Cancer, 11, 597-603. (Pubitemid 37152632)
31. Hoftijzer, H.C., Heemstra, K.A., Corssmit, E.P., et al. (2008) Quality of life in cured patients with differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 93, 200-203.
32. Pelttari, H., Sintonen, H., Schalin-Jantti, C., et al. (2009) Health-related quality of life in long-term follow-up of patients with cured TNM Stage I or II differentiated thyroid carcinoma. Clinical Endocrinology (Oxford), 70, 493-497.
33. Schultz, P.N., Stava, C., &, Vassilopoulou-Sellin, R., (2003) Health profiles and quality of life of 518 survivors of thyroid cancer. Head and Neck, 25, 349-356. (Pubitemid 36461107)
34. Roberts, K.J., Lepore, S.J., &, Urken, M.L., (2008) Quality of life after thyroid cancer: an assessment of patient needs and preferences for information and support. Journal of Cancer Education, 23, 186-191.
35. Lee, J.I., Kim, S.H., Tan, A.H., et al. (2010) Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea. Health and Quality of Life Outcomes, 8, 101.
36. Huang, S.M., Lee, C.H., Chien, L.Y., et al. (2004) Postoperative quality of life among patients with thyroid cancer. Journal of Advanced Nursing, 47, 492-499.
37. Schlenk, E.A., Erlen, J.A., Dunbar-Jacob, J., et al. (1998) Health-related quality of life in chronic disorders: a comparison across studies using the MOS SF-36. Quality of Life Research, 7, 57-65. (Pubitemid 28113965)
38. Goldney, R.D., Phillips, P.J., Fisher, L.J., et al. (2004) Diabetes, depression, and quality of life: a population study. Diabetes Care, 27, 1066-1070. (Pubitemid 38579767)
39. Juenger, J., Schellberg, D., Kraemer, S., et al. (2002) Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart, 87, 235-241. (Pubitemid 34177677)
40. Wee, H.L., Cheung, Y.B., Li, S.C., et al. (2005) The impact of diabetes mellitus and other chronic medical conditions on health-related Quality of Life: is the whole greater than the sum of its parts? Health and Quality of Life Outcomes, 3, 2.
41. Duntas, L.H., &, Biondi, B., (2007) Short-term hypothyroidism after Levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences. European Journal of Endocrinology, 156, 13-19. (Pubitemid 46553899)
42. Sawka, A.M., Goldstein, D.P., Brierley, J.D., et al. (2009) The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study. PLoS ONE, 4, e4191.
43. Luster, M., Felbinger, R., Dietlein, M., et al. (2005) Thyroid hormone withdrawal in patients with differentiated thyroid carcinoma: a one hundred thirty-patient pilot survey on consequences of hypothyroidism and a pharmacoeconomic comparison to recombinant thyrotropin administration. Thyroid, 15, 1147-1155. (Pubitemid 41720721)
44. Cooper, D.S., Doherty, G.M., Haugen, B.R., et al. (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 19, 1167-1214.
45. Hirsch, D., Ginat, M., Levy, S., et al. (2009) Illness perception in patients with differentiated epithelial cell thyroid cancer. Thyroid, 19, 459-465.
46. Ganz, P.A., Casillas, J., &, Hahn, E.E., (2008) Ensuring quality care for cancer survivors: implementing the survivorship care plan. Seminars in Oncology Nursing, 24, 208-217.